ClinicalTrials.gov
ClinicalTrials.gov Menu

Metabolic Syndrome and Leptin Level Associated With Fructose Consumption in Spain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00651001
Recruitment Status : Completed
First Posted : April 2, 2008
Last Update Posted : August 6, 2009
Sponsor:
Information provided by:
Hospital Mateo Orfila

Brief Summary:
A Food Frequency Questionnaire (FFQ), will be provided to 800 adults to assess overall fructose intake and this will be related to a number of features related to the metabolic syndrome, including serum leptin, characteristic features of metabolic syndrome (body mass index, waist circumference, plasma lipids, blood pressure, HOMA index,fasting glucose and fasting insulin levels) and other as: CRP, fibrinogen, homocysteine and uric acid.

Condition or disease
Healthy

Study Type : Observational
Estimated Enrollment : 800 participants
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Prevalence of Cardiovascular Risk Factors in Minorca - Spain
Study Start Date : June 2008
Actual Primary Completion Date : January 2009
Study Completion Date : June 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. Serum leptin levels as it relates to fructose intake [ Time Frame: Epidemiological association ]

Secondary Outcome Measures :
  1. Relationship of metabolic syndrome features with fructose intake. This includes measuring all 5 components of metabolic syndrome, assessing insulin resistance by HOMA, and measuring some markers of inflammation (CRP, fibrinogen, homocysteine) [ Time Frame: Epidemiological ]

Biospecimen Retention:   Samples Without DNA
Serum and urine collections.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
800 Adults, age 18 to 70
Criteria

Inclusion Criteria:

  • Adults, 18-70 years of age

Exclusion Criteria:

  • Diabetes
  • Kidney Failure
  • Heart Failure
  • Cancer

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00651001


Locations
Spain
Renal Unit of Mateo Orfila Hospital, Balearic Islands - Spain
Menorca, Balearic Islands, Spain, 07703
Sponsors and Collaborators
Hospital Mateo Orfila

Responsible Party: Perez-Pozo, Santos E. Lopez-Lillo, Julian. Johnson, Richard, Hospital Mateo Orfila, University of Florida
ClinicalTrials.gov Identifier: NCT00651001     History of Changes
Other Study ID Numbers: IbSalut-M-002
First Posted: April 2, 2008    Key Record Dates
Last Update Posted: August 6, 2009
Last Verified: August 2009

Keywords provided by Hospital Mateo Orfila:
fructose
leptin
metabolic syndrome
blood pressure
inflammation
Relationship of fructose intake to leptin levels
Relationship of fructose to metabolic syndrome
Relationship of fructose to inflammation parameters
Relationship of fructose to blood pressure

Additional relevant MeSH terms:
Metabolic Syndrome X
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases